Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B12 intakes

Tumor Biology

Volumn 35, Issue 12, 2014, Pages 11895-11901

  Jiang hua, Qiao ^a   De chuang, Jiao ^a   Zhen duo, Lu ^a   Shu de, Cui ^a   Zhenzhen, Liu ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Breast cancer; Folate; Methionine synthase; Methylenetetrahydrofolate reductase; Vitamin B

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; METHIONINE SYNTHASE; PYRIDOXINE; 5 METHYLTETRAHYDROFOLATE HOMOCYSTEINE METHYLTRANSFERASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CALORIC INTAKE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VITAMIN INTAKE; AGED; ALLELE; BREAST TUMOR; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; RISK FACTOR;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; ADULT; AGED; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; VITAMIN B 12; VITAMIN B 6;

EID: 84925282746     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-2456-1     Document Type: Article

References (35)

1. International Agency for Research on Cancer (IARC). Breast Cancer. Estimated incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. 2012. Accessed at 2014-2-18.
2. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov. 2006;5(3):219.
3. Ulrich CM. Nutrigenetics in cancer research—folate metabolism and colorectal cancer. J Nutr. 2005;135(11):2698.
4. 12 with risk of esophageal and gastric cancer in a large cohort study. Br J Cancer. 2014;110(5):1328.
5. Sun JY, Shen J, Thibodeaux J, Huang G, Wang Y, Gao J, et al. In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma. Laryngoscope. 2014;124(8):E312.
6. Pericleous M, Mandair D, Caplin ME. Diet and supplements and their impact on colorectal cancer. J Gastrointest Oncol. 2013;4(4):409.
7. Castillo-L C, Tur JA, Uauy R. Folate and breast cancer risk: a systematic review. Rev Med Chil. 2012;140(2):251.
8. Tio M, Andrici J, Eslick GD. Folate intake and the risk of breast cancer: a systematic review and meta-analysis. Breast Cancer Res Treat. 2014;145(2):513.
9. Zhang YF, Shi WW, Gao HF, Zhou L, Hou AJ, Zhou YH. Folate intake and the risk of breast cancer: a dose-response meta-analysis of prospective studies. PLoS One. 2014;9(6):e100044.
10. López-Cortés A, Jaramillo-Koupermann G, Muñoz MJ, et al. Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population. Am J Med Sci. 2013;346(6):447.
11. 12 & MTHFR, MTR Genotype and breast cancer risk. Pak J Med Sci. 2014;30(1):106.
12. Carvalho Barbosa Rde C, Menezes DC, Freire TF, Sales DC, Alencar VH, Rabenhorst SH. Associations of polymorphisms of folate cycle enzymes and risk of breast cancer in a Brazilian population are age dependent. Mol Biol Rep. 2012;39 (4):4899–907.
13. Tao MH, Shields PG, Nie J, Marian C, Ambrosone CB, McCann SE, et al. DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer Epidemiol Biomarkers Prev. 2009;18(3):998.
14. 12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan. Nutr Cancer. 2009;61(4):447.
15. de Cássia Carvalho Barbosa R, da Costa DM, Cordeiro DE, Vieira AP, Rabenhorst SH. Interaction of MTHFR C677T and A1298C, and MTR A2756G gene polymorphisms in breast cancer risk in a population in Northeast Brazil. Anticancer Res. 2012 Nov;32 (11):4805–11.
16. Wu XY, Ni J, Xu WJ, Zhou T, Wang X. Interactions between MTHFR C677T-A1298C variants and folic acid deficiency affect breast cancer risk in a Chinese population. Asian Pac J Cancer Prev. 2012;13(5):2199.
17. Akram M, Malik FA, Kayani MA. Mutational analysis of the MTHFR gene in breast cancer patients of Pakistani population. Asian Pac J Cancer Prev. 2012;13(4):1599.
18. Anderson G, Jun M, Choi K. Breast cancer screening for Korean women must consider traditional risks as well as two genetic risk factors: genetic polymorphisms and inheritable gene mutations. Cancer Nurs. 2007 May-Jun;30 (3):213–22.
19. Kim YI. Does a high folate intake increase the risk of breast cancer? Nutr Rev. 2006;64(10 Pt 1):468.
20. Xu X, Gammon MD, Wetmur JG, et al. B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2109.
21. Lin J, Lee IM, Cook NR, et al. Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr. 2008;87(3):734.
22. Tavani A, Malerba S, Pelucchi C, et al. Dietary folates and cancer risk in a network of case–control studies. Ann Oncol. 2012;23(10):2737.
23. Islam T, Ito H, Sueta A, et al. Alcohol and dietary folate intake and the risk of breast cancer: a case-control study in Japan. Eur J Cancer Prev. 2013;22(4):358.
24. Yang D, Baumgartner RN, Slattery ML, et al. Dietary intake of folate, B-vitamins and methionine and breast cancer risk among Hispanic and non-Hispanic white women. PLoS One. 2013;8(2):e54495.
25. Ulvik A, Ueland PM. Single nucleotide polymorphism (SNP) genotyping in unprocessed whole blood and serum by real-time PCR: application to SNPs affecting homocysteine and folate metabolism. Clin Chem. 2001;47(11):2050.
26. Hubner RA, Muir KR, Liu JF, et al. Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence. Cancer Epidemiol Biomarkers Prev. 2006;15(9):1607.
27. Galbiatti AL, da Silva LM, Ruiz-Cintra MT, et al. Association between 11 genetic polymorphisms in folate-metabolising genes and head and neck cancer risk. Eur J Cancer. 2012;48(10):1525.
28. Guimarães JL, Ayrizono Mde L, Coy CS, Lima CS. Gene polymorphisms involved in folate and methionine metabolism and increased risk of sporadic colorectal adenocarcinoma. Tumour Biol. 2011;32(5):853.
29. Sirachainan N, Wongruangsri S, Kajanachumpol S, et al. Folate pathway genetic polymorphisms and susceptibility of central nervous system tumors in Thai children. Cancer Detect Prev. 2008;32(1):72.
30. Bethke L, Webb E, Murray A, et al. Functional polymorphisms in folate metabolism genes influence the risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1195.
31. Wang ZG, Cui W, Yang LF, Zhu YQ, Wei WH. Association of dietary intake of folate and MTHFR genotype with breast cancer risk. Genet Mol Res. 2014;13(3):5446.
32. Shrubsole MJ, Shu XO, Li HL, Cai H, Yang G, Gao YT, et al. Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am J Epidemiol. 2011;173(10):1171.
33. Gao CM, Kazuo T, Tang JH, et al. MTHFR polymorphisms, dietary folate intake and risks to breast cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 2009;43(7):576.
34. Tao MH, Shields PG, Nie J, et al. DNA promoter methylation in breast tumors: no association with genetic polymorphisms in MTHFR and MTR. Cancer Epidemiol Biomarkers Prev. 2009;18(3):998.
35. Zhang CX, Ho SC, Chen YM, Lin FY, Fu JH, Cheng SZ. Dietary folate, vitamin B6, vitamin B12 and methionine intake and the risk of breast cancer by oestrogen and progesterone receptor status. Br J Nutr. 2011;106(6):936.